<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01092910</url>
  </required_header>
  <id_info>
    <org_study_id>0204</org_study_id>
    <nct_id>NCT01092910</nct_id>
  </id_info>
  <brief_title>Esteem Totally Implantable Hearing System</brief_title>
  <official_title>Esteem Totally Implantable Hearing System Clinical Trial U.S. Pivotal Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Envoy Medical Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Envoy Medical Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and efficacy of the Esteem Totally Implantable Hearing System in
      subjects suffering from mild to severe hearing loss.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Title: Esteem® Totally Implantable Hearing System Clinical Trial

      Purpose: To evaluate the safety and efficacy of the Esteem® Totally Implantable Hearing
      System (hereafter called the Esteem® System) in subjects suffering from mild to severe
      hearing loss.

      Trial Design: This pivotal trial is designed as a prospective, multi-center, non-randomized,
      clinical trial to evaluate the safety and efficacy of the Esteem® System. For this trial the
      subject will act as his or her own control.

      This trial has been designed to meet the United States' regulatory requirements.

      Enrollment Size: It is currently estimated that 50-60 subjects will be enrolled in this
      trial.

      Subject Population: Adult subjects who have mild to severe sensorineural hearing loss, have a
      healthy middle ear, have a speech discrimination score of equal to or better than 40%, and
      have previously worn a hearing aid for a minimum of 3 months with an average daily use rate
      of at least 4 hours are eligible for inclusion in the trial. See detailed inclusion/exclusion
      criteria for specifics.

      Primary Objectives:

        1. To demonstrate that the Esteem® System improves the speech threshold of sensitivity for
           hearing and identifying speech signals as well as or better than the pre-implant hearing
           aid (aided condition).

           Endpoint: Comparison of the speech reception threshold (SRT) using the Esteem® System (4
           months post activation) as compared to the pre-implant aided condition.

        2. To demonstrate that the Esteem® System at the 4 months post- activation visit is as
           effective as or better than the hearing aid for improving speech discrimination
           (intelligibility) as shown by the word recognition score at 50 dB.

           Endpoint: Comparison of the word recognition score using the Esteem® at 4 months
           post-activation compared to the pre-implant aided condition.

        3. To determine the incidence of Serious Adverse Device Effects (SADE) and the incidence
           rate of device failures and replacements.

           Endpoint: The analysis of the incidence of SADEs and device failures and replacements at
           each follow-up.

        4. To demonstrate that the subjects' cochlear function remains unchanged with the Esteem®
           System as shown by comparison of the subjects' pre-implant baseline bone conduction
           threshold versus the subjects' 4 month post-activation visit bone conduction threshold.

      Endpoint: Comparison of bone conduction threshold (BC) using forehead placement at 4 months
      post activation compared to the pre-implant BC threshold.

      Secondary Objectives:

        1. To demonstrate that the Esteem® System at the 4 months post activation visit improves
           the 3-frequency (500, 1000, and 2000 Hz) pure tone average (PTA) when compared to the
           baseline unaided condition.

        2. To demonstrate that the Esteem® System at the 4 months post-activation visit is as
           effective as or better than the hearing aid for improving speech discrimination
           (intelligibility) as shown by the QuickSIN (speech in noise) test results.

        3. To show that the Esteem® System improves Quality-of-Life when compared to the baseline
           aided condition as shown by APHAB results.

        4. To gather subject feedback and comments on the use of the Esteem® System relative to the
           pre-implant hearing aid (aided condition) as shown by the Esteem® Questionnaire.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SRT Improvement</measure>
    <time_frame>4 Months Post Activation</time_frame>
    <description>Comparison of the speech reception threshold (SRT) using the Esteem System as compared to the pre-implant aided condition</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SRT Improvement</measure>
    <time_frame>10 Months Post-Activation</time_frame>
    <description>Comparison of the speech reception threshold (SRT) using the Esteem System as compared to the pre-implant aided condition</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Word Recognition Score Improvement</measure>
    <time_frame>4 Months Post Activation</time_frame>
    <description>Comparison of the word recognition score using the Esteem compared to the pre-implant aided condition</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Word Recognition Score Improvement</measure>
    <time_frame>10 Months Post Activation</time_frame>
    <description>Comparison of the word recognition score using the Esteem compared to the pre-implant aided condition</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SADEs</measure>
    <time_frame>10 Months Post-Activation</time_frame>
    <description>The incidence of Serious Adverse Device Effects (SADE) and the incidence rate of device failures and replacements</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of Cochlear Function</measure>
    <time_frame>4 and 10 Months Post-Activation</time_frame>
    <description>Comparison of the bone conduction threshold with forehead placement at the 4 month post-activation follow-up compared to the pre-implant bone conduction threshold.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PTA Improvement</measure>
    <time_frame>4 and 10 Months Post-Activation</time_frame>
    <description>Comparison of the 3-frequency (500, 1000, and 2000 Hz) pure-tone average (PTA) using the Esteem System to the PTA measured in the baseline unaided condition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QuickSIN</measure>
    <time_frame>4 and 10 Months Post-Activation</time_frame>
    <description>To assess whether the Esteem System is as effective as or better than the pre-implant hearing aid for improving speech discrimination (intelligibility) as shown by the QuickSIN (speech in noise) test results.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>APHAB</measure>
    <time_frame>4 and 10 Months Post-Activation</time_frame>
    <description>To assess whether the Esteem System improves Quality-of-Life when compared to the baseline aided condition as shown by APHAB results</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Esteem Questionnaire</measure>
    <time_frame>4 and 10 Months Post Activatio-</time_frame>
    <description>To gain subject feedback and comments on the use of the Esteem System relative to the pre-implant hearing aid (aided condition) as shown by the Esteem Questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Mild to Severe Sensorineural Hearing Loss</condition>
  <arm_group>
    <arm_group_label>Esteem Implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects are implanted with the Esteem Totally Implantable Hearing System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Esteem Totally Implantable Hearing System</intervention_name>
    <description>The Esteem System is a totally implantable hearing system designed to improve hearing in adult subjects suffering from mild to severe hearing loss that is sensorineural in origin.</description>
    <arm_group_label>Esteem Implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is 18 years old

          -  Subject understands the nature of the procedure and has signed the Subject Informed
             Consent Form prior to the procedure

          -  Subject is willing and able to comply with specified follow-up evaluations and
             understands the audiological test procedures and use of the Esteem System.

          -  Subject has mild to severe sensorineural hearing loss between 500 and 4000 Hz in the
             ear to be implanted with pure tone air-conduction threshold levels within the limits
             of a Hearing Aid (HA) as follow:

        Freq (Hz) 500 1000 2000 3000 4000 LL* (dB HL) 30 35 35 35 35 UL* (dB HL) 100 100 100 100
        100

        *LL = Lower Level; UL = Upper Level

          -  Subject's air-bone gap is no greater than 10 dB at 4 of the 5 following frequencies:
             500, 1000, 2000, 3000 and 4000 Hz.

          -  Subject has an unaided maximum word recognition score of greater than or equal to 60%
             with recorded delivery using a phonetically balanced word list at SRT + 40 dB or at
             maximum tolerable presentation level.

          -  Subject is a current user of a properly functioning and appropriately fit hearing aid.
             This is defined as the subject has used this aid for at least four (4) hours (average)
             per day (in the ear to be implanted) for at least three (3) months for a new aid or
             one (1) month for an adjusted aid.

          -  Subject's hearing aid, in the ear to be implanted, shall appropriately fit optimally.

          -  Subject has normally functioning eustachian tube

          -  Subject has normal tympanic membrane

          -  Subject has a normal middle ear anatomy

          -  Subject has adequate space for Esteem System implant determined via fine cut temporal
             bone CT scan

          -  Subject is a native speaker of the English language.

          -  Subject is a hearing aid user in the ear to be implanted.

        Exclusion Criteria:

          -  Subject has a history of post-adolescent chronic middle ear infections, inner ear
             disorders or recurring vertigo requiring treatment, disorders such as mastoiditis,
             Hydrops or Meniere's syndrome or disease

          -  Subject has a history of otitis externa or eczema for the outer ear canal and the
             investigator believes this will affect the Esteem System implantation

          -  Subject has cholesteatoma or destructive middle ear disease

          -  Subject has life expectancy of two (2) years due to other medical conditions

          -  Subject has retrocochlear or central auditory disorders

          -  Subject is known to be suffering from any psychological, developmental, physical, or
             emotional disorder that the investigator feels would interfere with the surgery or
             follow-up testing

          -  Subject has a known history of fluctuating air conduction and/or bone conduction
             hearing loss over a one-year period of 15 dB in either direction at 2 or more
             frequencies (from 500 - 4000 Hz)

          -  Subject has sudden hearing loss due to unknown cause

          -  Subject has a history of disabling tinnitus, defined as tinnitus which required
             treatment.

          -  Subject is unable to adequately perform audiological testing

          -  Subject has a medical condition or undergoing a treatment that may affect healing and
             the investigator does not believe the subject is a good candidate for the trial.

          -  Subject has diabetes that is not well controlled with medication or diet and the
             investigator does not believe in his best medical judgment that the subject would be a
             good candidate for the trial

          -  Subject is pregnant at the time of device implant

          -  Subject has a history of keloid formation

          -  Subject has known hypersensitivity to silicone rubber, polyurethane, stainless steel,
             titanium and/or gold
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jack A. Shohet, M.D.</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_official>
    <last_name>Eric M. Kraus, M.D., M.S.</last_name>
    <role>Principal Investigator</role>
    <affiliation>F.A.C.S.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter J. Catalano, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>F.A.C.S.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hoag Memorial Hospital Presbyterian</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92658</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shohet Ear Associates</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lahey Clinic, Inc.</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Surgical Care Affiliates</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ear Center of Greensboro</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.envoymedical.com</url>
    <description>Envoy Medical Corporation Official Web Site</description>
  </link>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2010</study_first_submitted>
  <study_first_submitted_qc>March 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2010</study_first_posted>
  <results_first_submitted>January 26, 2016</results_first_submitted>
  <results_first_submitted_qc>January 26, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 23, 2016</results_first_posted>
  <last_update_submitted>January 26, 2016</last_update_submitted>
  <last_update_submitted_qc>January 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sensorineural</keyword>
  <keyword>Hearing Loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
    <mesh_term>Hearing Loss, Sensorineural</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were recruited at three different sites:
The Ear Center of Greensboro Greensboro, NC 27401
Shohet Ear Associates Medical Group, Inc. Newport Beach, CA 92663
Lahey Clinic Burlington, MA 01805</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Esteem Implant</title>
          <description>Subjects are implanted with the Esteem Totally Implantable Hearing System
Esteem Totally Implantable Hearing System: The Esteem System is a totally implantable hearing system designed to improve hearing in adult subjects suffering from mild to severe hearing loss that is sensorineural in origin.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>4 Month Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>10 Month Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Esteem Implant</title>
          <description>Subjects implanted with the Esteem Totally Implantable Hearing System</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="57"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52.9" spread="15.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>SRT Improvement</title>
        <description>Comparison of the speech reception threshold (SRT) using the Esteem System as compared to the pre-implant aided condition</description>
        <time_frame>4 Months Post Activation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Esteem Implant</title>
            <description>Subjects implanted with the Esteem Totally Implantable Hearing System
The Esteem System is a totally implantable hearing system designed to improve hearing in adult subjects suffering from mild to severe hearing loss that is sensorineural in origin.</description>
          </group>
        </group_list>
        <measure>
          <title>SRT Improvement</title>
          <description>Comparison of the speech reception threshold (SRT) using the Esteem System as compared to the pre-implant aided condition</description>
          <units>dB improvement</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.6" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>SRT Improvement</title>
        <description>Comparison of the speech reception threshold (SRT) using the Esteem System as compared to the pre-implant aided condition</description>
        <time_frame>10 Months Post-Activation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Esteem Implant</title>
            <description>Subjects are implanted with the Esteem Totally Implantable Hearing System
Esteem Totally Implantable Hearing System: The Esteem System is a totally implantable hearing system designed to improve hearing in adult subjects suffering from mild to severe hearing loss that is sensorineural in origin.</description>
          </group>
        </group_list>
        <measure>
          <title>SRT Improvement</title>
          <description>Comparison of the speech reception threshold (SRT) using the Esteem System as compared to the pre-implant aided condition</description>
          <units>dB improvement</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.4" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Word Recognition Score Improvement</title>
        <description>Comparison of the word recognition score using the Esteem compared to the pre-implant aided condition</description>
        <time_frame>4 Months Post Activation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Esteem Implant</title>
            <description>Subjects are implanted with the Esteem Totally Implantable Hearing System
Esteem Totally Implantable Hearing System: The Esteem System is a totally implantable hearing system designed to improve hearing in adult subjects suffering from mild to severe hearing loss that is sensorineural in origin.</description>
          </group>
        </group_list>
        <measure>
          <title>Word Recognition Score Improvement</title>
          <description>Comparison of the word recognition score using the Esteem compared to the pre-implant aided condition</description>
          <units>improvement in % correct</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.7" spread="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Word Recognition Score Improvement</title>
        <description>Comparison of the word recognition score using the Esteem compared to the pre-implant aided condition</description>
        <time_frame>10 Months Post Activation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Esteem Implant</title>
            <description>Subjects are implanted with the Esteem Totally Implantable Hearing System
Esteem Totally Implantable Hearing System: The Esteem System is a totally implantable hearing system designed to improve hearing in adult subjects suffering from mild to severe hearing loss that is sensorineural in origin.</description>
          </group>
        </group_list>
        <measure>
          <title>Word Recognition Score Improvement</title>
          <description>Comparison of the word recognition score using the Esteem compared to the pre-implant aided condition</description>
          <units>improvement in % correct</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.8" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PTA Improvement</title>
        <description>Comparison of the 3-frequency (500, 1000, and 2000 Hz) pure-tone average (PTA) using the Esteem System to the PTA measured in the baseline unaided condition</description>
        <time_frame>4 and 10 Months Post-Activation</time_frame>
        <population>10 month data reported</population>
        <group_list>
          <group group_id="O1">
            <title>Esteem Implant</title>
            <description>Subjects are implanted with the Esteem Totally Implantable Hearing System
Esteem Totally Implantable Hearing System: The Esteem System is a totally implantable hearing system designed to improve hearing in adult subjects suffering from mild to severe hearing loss that is sensorineural in origin.</description>
          </group>
        </group_list>
        <measure>
          <title>PTA Improvement</title>
          <description>Comparison of the 3-frequency (500, 1000, and 2000 Hz) pure-tone average (PTA) using the Esteem System to the PTA measured in the baseline unaided condition</description>
          <population>10 month data reported</population>
          <units>dB improvement</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>QuickSIN</title>
        <description>To assess whether the Esteem System is as effective as or better than the pre-implant hearing aid for improving speech discrimination (intelligibility) as shown by the QuickSIN (speech in noise) test results.</description>
        <time_frame>4 and 10 Months Post-Activation</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>APHAB</title>
        <description>To assess whether the Esteem System improves Quality-of-Life when compared to the baseline aided condition as shown by APHAB results</description>
        <time_frame>4 and 10 Months Post-Activation</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Esteem Questionnaire</title>
        <description>To gain subject feedback and comments on the use of the Esteem System relative to the pre-implant hearing aid (aided condition) as shown by the Esteem Questionnaire.</description>
        <time_frame>4 and 10 Months Post Activatio-</time_frame>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>SADEs</title>
        <description>The incidence of Serious Adverse Device Effects (SADE) and the incidence rate of device failures and replacements</description>
        <time_frame>10 Months Post-Activation</time_frame>
        <population>Includes all events, cumulatively, from enrollment through 10-month followup</population>
        <group_list>
          <group group_id="O1">
            <title>Esteem Implant</title>
            <description>Subjects are implanted with the Esteem Totally Implantable Hearing System
Esteem Totally Implantable Hearing System: The Esteem System is a totally implantable hearing system designed to improve hearing in adult subjects suffering from mild to severe hearing loss that is sensorineural in origin.</description>
          </group>
        </group_list>
        <measure>
          <title>SADEs</title>
          <description>The incidence of Serious Adverse Device Effects (SADE) and the incidence rate of device failures and replacements</description>
          <population>Includes all events, cumulatively, from enrollment through 10-month followup</population>
          <units>events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Assessment of Cochlear Function</title>
        <description>Comparison of the bone conduction threshold with forehead placement at the 4 month post-activation follow-up compared to the pre-implant bone conduction threshold.</description>
        <time_frame>4 and 10 Months Post-Activation</time_frame>
        <population>10-month results for difference in BC PTA (pre-implant minus post-Esteem) are shown</population>
        <group_list>
          <group group_id="O1">
            <title>Esteem Implant</title>
            <description>Subjects are implanted with the Esteem Totally Implantable Hearing System
Esteem Totally Implantable Hearing System: The Esteem System is a totally implantable hearing system designed to improve hearing in adult subjects suffering from mild to severe hearing loss that is sensorineural in origin.</description>
          </group>
        </group_list>
        <measure>
          <title>Assessment of Cochlear Function</title>
          <description>Comparison of the bone conduction threshold with forehead placement at the 4 month post-activation follow-up compared to the pre-implant bone conduction threshold.</description>
          <population>10-month results for difference in BC PTA (pre-implant minus post-Esteem) are shown</population>
          <units>dB difference</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Cumulative through 10 Month Post-Activation</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Esteem Implant</title>
          <description>Subjects implanted with the Esteem Totally Implantable Hearing System
Esteem Totally Implantable Hearing System: The Esteem System is a totally implantable hearing system designed to improve hearing in adult subjects suffering from mild to severe hearing loss that is sensorineural in origin.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Limited benefit</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Incision Breakdown</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Pain and Facial Weakness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>4</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear effusion/fluid</sub_title>
                <counts group_id="E1" events="17" subjects_affected="17" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Dizziness/vertigo</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Ear cracking/roaring</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Otitis externa/TM</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Headache/Pain (post-op)</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Chorda Tympani/Taste Disturbance</sub_title>
                <counts group_id="E1" events="24" subjects_affected="23" subjects_at_risk="57"/>
              </event>
              <event>
                <sub_title>Facial weakness/paralysis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Incision discomfort/breakdown</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Elizabeth Anderson, PhD</name_or_title>
      <organization>Envoy Medical Corp.</organization>
      <phone>651-361-8080</phone>
      <email>landerson@envoymedical.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

